Loren Miller, M.D., M.P.H. has found no reliable epidemiological or clinical risk factors that could distinguish patients with CA-MRSA infection from patients with CA-MSSA infection. “What this means,” says Dr. Miller, “is that the average Joe or Jane can get CA-MRSA.”
Doctors have long known that patients treated for Hodgkin disease are at an increased risk for heart attacks.
CMS officials on monday in a preliminary decision rejected a request from Cyberonics for Medicare coverage of the vagus nerve stimulator as a treatment for depression.
Researchers have discovered an enzyme that has an unexpectedly profound impact on fat metabolism. The enzyme is a master regulator that controls metabolic responses to a deficiency of essential amino acids in the diet. The research could lead to treatments for obesity and malnutrition and to preventions for type 2 diabetes and heart attacks.
nterrupting nerve signals to the liver can prevent diabetes and hypertension in mice, according to scientists at Washington University School of Medicine in St. Louis. The finding is reported in the February issue of the journal Cell Metabolism.
The first, pan-European guidelines to be published on the treatment of valvular heart disease, diabetes and cardiovascular diseases have made a series of new recommendations which experts hope will contribute to improving the outcome of patients with these diseases.
Increasing the ability to identify sentinel nodes?the very first lymph nodes that trap cancer cells draining away from a breast lesion site?has a major impact in the treatment and outcome of breast cancer patients, possibly eliminating the need for unnecessary and painful surgery.
President Bush on monday released his $2.8 trillion fiscal year 2008 budget proposal, which would allocate $5.4 billion for the President’s Emergency Plan for AIDS Relief.
Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health on National Black HIV/AIDS Awareness and Information Day February 7, 2007.
A toxin derived from a reclusive sea creature resembling a translucent doughnut has inspired UT Southwestern Medical Center researchers to develop a related compound that shows promise as a cancer treatment.